Search Within

Aaron David Goldberg

Formats
  1. Meeting Abstract (71)
  2. Journal Article (32)
  3. Research Letter (6)
  4. Correspondence (4)
  5. Editorial (3)
  6. Review (2)
  7. Book Section (1)
Groups
  1. Adult Leukemia (119)
  2. Center for Hematologic Malignancies (119)
  3. Department of Medicine (119)
  4. Hematologic Malignancies, Division of (119)
  5. Hematology-Oncology Fellows (119)
  6. Weinberg Fellows (119)

More Groups

People
  1. Martin Tallman (49)
  2. Eytan Stein (43)
  3. Christopher Famulare (38)
  4. Andriy Derkach (22)
  5. Ross Levine (21)
  6. Jan Bewersdorf (20)

More People

Years
  1. 2025 (6)
  2. 2024 (20)
  3. 2023 (20)
  4. 2022 (15)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (63)
  2. Leukemia and Lymphoma (8)
  3. American Journal of Hematology (6)
  4. Blood Advances (5)
  5. Journal of Clinical Oncology (5)
  6. British Journal of Haematology (4)

More Publications

Publishers
  1. American Society of Hematology (68)
  2. Taylor & Francis Group (8)
  3. American Society of Clinical Oncology (6)
  4. John Wiley & Sons, Inc. (6)
  5. Elsevier Inc. (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (119)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensive therapy for NPM1 mutant AML patients: Negative impact of FLT3-ITD(high)but not FLT3-ITD(low) and FLT3TKD and role of transplant in patients over 60 years of age
    Meeting Abstract

    Winer, E. S.; Flamand, Y.; Shallis, R. M.; Stempel, J. M.; Goldberg, A. D.; Stahl, M. F.; Patel, A. A.; Duvall, A. S.; Abaza, Y.; Oh, T. S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with TP53-mutated AML after first relapse or with primary refractory disease: Results from consortium on myeloid malignancies and neoplastic diseases (COMMAND)
    Meeting Abstract

    Badar, T.; Atallah, E. L.; Saliba, A. N.; Shallis, R. M.; Stahl, M. F.; Bewersdorf, J. P.; Correia, G. S. D.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia
    Meeting Abstract

    Robinson, T.; Bowman, R. L.; Persaud, S.; Liu, Y.; Gao, Q.; Zhang, J. P.; Sun, X.; Sciambi, A.; Llanso, A.; Famulare, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors of long-term outcome in TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplant after first- or second-line therapy: Results from the consortium on myeloid malignancies and neoplastic diseases (COMMAND)
    Meeting Abstract

    Badar, T.; Atallah, E. L.; Shallis, R. M.; Saliba, A. N.; Stahl, M. F.; Bewersdorf, J. P.; Grenet, J.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Investigational venetoclax combination therapy in acute myeloid leukemia - A systematic review and meta-analysis
    Research Letter

    Shimony, S.; Rozental, A.; Bewersdorf, J. P.; Goldberg, A. D.; Stein, E. M.; Grimshaw, A. A.; Stone, R. M.; DeAngelo, D. J.; Wolach, O.; Stahl, M.
    Haematologica (2022)

    Fulltext@MSK | Save
  • Racial disparities in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Badar, T.; Litzow, M. R.; Shallis, R.; Stahl, M.; Bewersdorf, J. P.; Saliba, A. N.; de Camargo Correia, G. S.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Wang, E. S.; Goldberg, A. D.; Walter, R. B.; Collins, R.; Stone, R. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
    Journal Article

    Prebet, T.; Goldberg, A. D.; Jurcic, J. G.; Khaled, S.; Dail, M.; Feng, Y.; Green, C.; Li, C.; Ma, C.; Medeiros, B. C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
    Correspondence

    Badar, T.; Atallah, E.; Shallis, R. M.; Goldberg, A. D.; Patel, A.; Abaza, Y.; Bewersdorf, J. P.; Saliba, A. N.; Correia, G. S. D. C.; Murthy, G.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save